Planned launch pricing
Pricing
Every price Ruby plans to charge at launch, on one page, posted now so you can hold us to it later. Medication for fibroids manages symptoms. It does not remove fibroids, and symptoms return after effective therapy stops.[1]
Not purchasable today
There is no checkout anywhere on this site. Programs open at launch, only under Black women clinical leadership, and the waitlist decides onboarding order.
Fibroid care first
Core program
Fibroid symptom management
$69per month, planned
Care built around the bleeding: tranexamic acid where it fits, hormonal options, oral iron with ferritin monitoring, and referral coordination when a procedure conversation is due. Tranexamic acid reduced fibroid-associated heavy bleeding in the reviewed evidence; it does not treat the fibroid itself.[1]
Escalation, by referral
GnRH antagonist combination
$69per month alongside a specialist referral, planned
Relugolix- and elagolix-based combination therapies are branded, prior-authorization heavy, and limited to 24 months of use because of bone-density loss that may not fully recover, with boxed warnings for blood-clot risk.[2][3] Ruby coordinates; a specialist manages. This line exists for honesty, not margin.
Core program
HRT (patch, oral, topical)
$49per month, planned
Hormone therapy prescribed only where a clinician decides it fits your history, with the published cautions stated in plain words during intake, not buried in a PDF.
Weight care
GLP-1 based programs with a first-month price, then a plan term. Longer terms carry the lower overall rate. These are planned prices, not offers, and no medication is dispensed through this site.
Weight care, core program
Semaglutide
$99first month, then your plan below
| Plan term | Plan price |
|---|---|
| 1 month | $190 |
| 3 months | $399 |
| 6 months | $714 |
| 12 months | $1,188 |
Online medical intake first, prescription only if a licensed clinician decides it fits, and the clinician can say no.
Weight care, core program
Tirzepatide
$149first month, then your plan below
| Plan term | Plan price |
|---|---|
| 1 month | $239 |
| 3 months | $627 |
| 6 months | $1,194 |
| 12 months | $2,148 |
Online medical intake first, prescription only if a licensed clinician decides it fits, and the clinician can say no.
Add-ons
Add-on
Hair (traction alopecia, CCCA)
$45per month, planned
Topical minoxidil, tension-reduction counseling, and anti-inflammatory therapy where CCCA is the diagnosis.[5] CCCA is a scarring alopecia: hairs will not regrow from permanently damaged follicles, so treatment aims to stop progression.[4] Any off-label option is named as off-label during intake.
Add-on
Sleep and mood
$79per month, planned
Non-controlled, first-line options only, attached to a core program. Screening comes before any prescription conversation, and crisis care is never sold here: in a mental health crisis, call or text 988 now.
The guardrails under these prices
- No available treatment permanently stops fibroid growth, and symptoms return after effective therapy stops.[1] Every fibroid plan is priced and described with that sentence attached.
- Procedures are referrals, not products. The hormonal IUD, IV iron, embolization and myomectomy belong with the clinicians and centers that do them, and Ruby's job is getting you there with your records in order.
- Nothing here is billable until launch, and launch happens only under Black women clinical leadership. Prices can move before launch; if they do, the change will be visible on this page, not hidden in an email.
Can I buy any of this today?
No. There is no checkout on this site, no intake, and no clinical team yet. Programs open at launch, and the waitlist decides onboarding order.
Why post prices before anything is buyable?
Because price surprises are their own kind of dismissal. Posting the ladder now means you can compare it, question it, and hold us to it at launch.
What happens if a clinician says no?
Then no prescription happens. Every program runs through a licensed clinician's judgment at launch, and the answer can be no. We would rather lose the sale than write something that shouldn't exist.
Sources cited on this page
- [1] Barseghyan M, Chae-Kim J, Catherino WH, The efficacy of medical management of leiomyoma-associated heavy menstrual bleeding, F&S Reports (2023), PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10958631/. Accessed 2026-08-06.
- [2] Pfizer press release, Myovant Sciences and Pfizer receive FDA approval for MYFEMBREE (2021). https://www.pfizer.com/news/press-release/press-release-detail/myovant-sciences-and-pfizer-receive-fda-approval-myfembreer. Accessed 2026-08-06.
- [3] AbbVie, ORIAHNN patient site. https://www.oriahnn.com/. Accessed 2026-08-06.
- [4] StatPearls, Central centrifugal cicatricial alopecia, NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK559187/. Accessed 2026-08-06.
- [5] StatPearls, Traction alopecia, NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK470434/. Accessed 2026-08-06.
Programs open at launch
The guides are free now. The care comes after the gate.
The waitlist is free and it is the only signup that exists. Care launches only under Black women clinical leadership, and until then the guides cite their sources and cost nothing.